Preclinical pharmacokinetics and in vitro metabolism of BMS-690514, a potent inhibitor of EGFR and VEGFR2
Version of Record online: 17 FEB 2010
Copyright © 2010 Wiley-Liss, Inc.
Journal of Pharmaceutical Sciences
Volume 99, Issue 8, pages 3579–3593, August 2010
How to Cite
Marathe, P., Tang, Y., Sleczka, B., Rodrigues, D., Gavai, A., Wong, T., Christopher, L. and Zhang, H. (2010), Preclinical pharmacokinetics and in vitro metabolism of BMS-690514, a potent inhibitor of EGFR and VEGFR2. J. Pharm. Sci., 99: 3579–3593. doi: 10.1002/jps.22099
- Issue online: 15 JUN 2010
- Version of Record online: 17 FEB 2010
- Manuscript Accepted: 11 JAN 2010
- Manuscript Revised: 9 JAN 2010
- Manuscript Received: 20 OCT 2009
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!